| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOCRYST PHARMACEUTICALS INC | Chief R&D Officer | Common Stock | 377K | $2.83M | $7.50 | 31 Mar 2025 | Direct |
| ImmunoGen, Inc. | Director | Common Stock | 0 | $0 | $29.30 | 12 Feb 2024 | Direct |
| ImmunoGen, Inc. | Director | Deferred Share Unit | 0 | $0 | $29.30 | 12 Feb 2024 | Direct |
| ImmunoGen, Inc. | Director | Restricted Stock Unit | 0 | $0 | $29.30 | 12 Feb 2024 | Direct |
| BIOCRYST PHARMACEUTICALS INC | Chief R&D Officer | Emp. Stock Option (Right to Buy) | 261K | 19 Dec 2024 | Direct | ||
| ImmunoGen, Inc. | Director | Stock Option (Right to Buy) | 0 | 12 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | 31 Mar 2025 | 1 | -$56.4K | 4 | Chief R&D Officer | 02 Apr 2025, 16:18 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 19 Dec 2024 | 3 | -$45K | 4 | Chief R&D Officer | 23 Dec 2024, 16:15 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 14 Dec 2024 | 1 | -$53.8K | 4 | Chief R&D Officer | 17 Dec 2024, 16:03 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 14 May 2024 | 1 | $176K | 4 | Chief R&D Officer | 15 May 2024, 07:17 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 31 Mar 2024 | 1 | -$38.2K | 4 | Chief R&D Officer | 02 Apr 2024, 16:21 |
| IMGN | ImmunoGen, Inc. | 12 Feb 2024 | 6 | $0 | 4 | Director | 12 Feb 2024, 16:47 |
| IMGN | ImmunoGen, Inc. | 29 Dec 2023 | 1 | $7.47K | 4 | Director | 03 Jan 2024, 17:42 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 19 Dec 2023 | 1 | -$33.8K | 4 | Chief R&D Officer | 20 Dec 2023, 16:42 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 14 Dec 2023 | 3 | -$19.5K | 4 | Chief R&D Officer | 18 Dec 2023, 16:47 |
| IMGN | ImmunoGen, Inc. | 29 Sep 2023 | 1 | $7.49K | 4 | Director | 02 Oct 2023, 17:07 |
| IMGN | ImmunoGen, Inc. | 30 Jun 2023 | 1 | $7.49K | 4 | Director | 05 Jul 2023, 17:52 |
| IMGN | ImmunoGen, Inc. | 14 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 16:50 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 03 Apr 2023 | 1 | -$58K | 4 | Chief R&D Officer | 05 Apr 2023, 16:33 |
| IMGN | ImmunoGen, Inc. | 31 Mar 2023 | 1 | $7.5K | 4 | Director | 04 Apr 2023, 16:54 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 19 Dec 2022 | 2 | $0 | 4 | Chief R&D Officer | 21 Dec 2022, 15:41 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 15 Dec 2022 | 1 | -$34K | 4 | Chief R&D Officer | 19 Dec 2022, 15:58 |
| IMGN | ImmunoGen, Inc. | 15 Jun 2022 | 2 | $108K | 4 | Director | 17 Jun 2022, 16:09 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 01 Apr 2022 | 1 | -$123K | 4 | Chief R&D Officer | 04 Apr 2022, 16:32 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 14 Dec 2021 | 2 | $0 | 4 | Chief R&D Officer | 16 Dec 2021, 16:06 |
| IMGN | ImmunoGen, Inc. | 22 Sep 2021 | 2 | $263K | 4 | Director | 23 Sep 2021, 16:35 |
| IMGN | ImmunoGen, Inc. | 22 Sep 2021 | 0 | $0 | 3 | Director | 23 Sep 2021, 16:34 |